National ms society | prozac (fluoxetine)
Prozac fluoxetine. At the documents had been released in earlier litigation. 19 The British Medical Journal ultimately retracted its claim that the documents had not been previously disclosed, and apologized to Eli Lilly. 20 Also in 2005, an internal document purportedly from Eli Lilly and Co. made public showed that the drug maker had data more than 15 years old showing that patients on its antidepressant Prozac were far more likely to attempt suicide and show hostility than were patients on other antidepressants and that the company attempted to minimize public awareness of the side effects. The 1988 document indicated that 3.7 percent of patients attempted suicide while on the blockbuster drug, a rate more than 12 times that cited for any of four other commonly used antidepressants. The document, which cited clinical trials of 14,198 patients on fluoxetine -- the generic name for Prozac -- also stated that 2.3 percent of users suffered psychotic depression while on the drug, more than double the next-
[pdf] prozac /sarafem (fluoxetine) and pregnancy
Highest rate of patients using another antidepressant. The document was provided to CNN by the office of Rep. Maurice Hinchey, D-New York, who called for tightening FDA regulations on drug safety. "The case demonstrates the need for Congress to mandate the complete disclosure of all clinical studies for FDA-approved drugs so that patients and their doctors, not the drug companies, decide whether the benefits of taking a certain medicine outweigh the risks," Rep. Hinchey said. On 10th December 2006 it was again reported, this time in the Observer newspaper, that Prozac was building up in some of the UK's drinking supplies due to the large number of people now taking it. The newspaper reported that the Environment Agency is conducting tests and is presuming that the Prozac is very, very diluted. Nonetheless, the paper reported some environmental experts have voiced concern at the findings. edit Prozac for children On 7th June 2006, the European Medicines Agency had announced that Prozac